Phibro Animal Health (PAHC) Cash from Investing Activities (QoQ) (2013 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Cash from Investing Activities (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11% |
| Mar 31, 2026 | 2.20% |
| Dec 31, 2025 | 18.23% |
| Sep 30, 2025 | -198.75% |
| Jun 30, 2025 | 61.46% |
| Mar 31, 2025 | 92.99% |
| Dec 31, 2024 | -8,789.86% |
| Sep 30, 2024 | 67.84% |
| Jun 30, 2024 | -906.28% |
| Mar 31, 2024 | 104.55% |
| Dec 31, 2023 | -61.94% |
| Sep 30, 2023 | -49.31% |
| Jun 30, 2023 | 72.78% |
| Mar 31, 2023 | -285.09% |
| Dec 31, 2022 | 39.25% |
| Sep 30, 2022 | -69.28% |
| Jun 30, 2022 | 4.06% |
| Mar 31, 2022 | -156.60% |
| Dec 31, 2021 | 185.01% |
| Sep 30, 2021 | -187.43% |